MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    miRNAs from blood serum as an early diagnostic biomarker for Parkinson’s disease: A study in an animal model

    MD. Ahmad, PSD. Dholaniya (Hyderabad, India)

    Objective: This work aims to elucidate miRNA-based biomarkers for the early stages of Parkinson`s Disease diagnosis in a chemically induced PD rat model. Background: The…
  • 2023 International Congress

    Comparision of objective Parkinson’s disease monitoring systems and the interpretations of results

    G. Kilincalp, F. Grahn, H. Sabir, D. von Below, A. Jeppsson, A. Sjöström, F. Bergquist (Gothenburg, Sweden)

    Objective: To examine the agreeement between two objective Parkinson’s disease (PD) monitoring systems (PKG and STAT-ON) and clinical information from a resident physician’s interview or…
  • 2023 International Congress

    Detailed illustration of a Turkish patient with homozygous C19ORF12 mutation

    H. Onder, T. Comoglu, S. Comoglu (Ankara, Turkey)

    Objective: To illustrate a rare Turkish patient with homozygous C19ORF12 mutation and discuss limitations regarding the current terminology and classification. Background: Neurodegeneration with brain iron…
  • 2023 International Congress

    Adult onset cerebrotendinous xanthomatosis (CTX) with parkinsonism responding to bilateral subthalamic nucleus deep brain stimulation

    R. Tilney, N. Dingli, E. Said, L. Zrinzo, J. Aquilina (London, United Kingdom)

    Objective: To describe a young male diagnosed with cerebrotendinous xanthomatosis who responded favourably to subthalamic nucleus deep brain stimulation (STN-DBS). Background: Cerebrotendinous Xanthomatosis is an…
  • 2023 International Congress

    Sex-Specific Association Between Plasma Vitamin D and Parkinson’s Disease: A Mendelian Randomization Study

    T. Antar, H. Iwaki (Bethesda, USA)

    Objective: To investigate whether there is a sex-specific causal relationship between plasma vitamin D levels and the risk of Parkinson's disease (PD). Background: Prior studies…
  • 2023 International Congress

    Monocular Ocular Bobbling with Holmes Tremor Due to Ruptured Cavernoma

    S. Virameteekul, P. Panyakaew,, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To describe a rare and unique manifestation of cavernoma-induced brain injury, specifically the occurrence of monocular ocular bobbing with unilateral Holmes tremor. It aims…
  • 2023 International Congress

    Reconstruction of the dentato-rubro-thalamic tract based on the anatomy of the rubral wing

    A. Berger, J. Chung, Z. Schnurman, L. Pan, T. Shepherd, A. Mogilner (New York, USA)

    Objective: We investigated reconstructing the entire dentato-rubro-thalamic tract (DRT) by an anatomical “rubral wing”-based tractography and compare its correlation with clinical outcomes to those of…
  • 2023 International Congress

    The spectrum of GBA mutations in the Korean population with Parkinson’s disease

    J. Hwangbo, J. Lee, SC. Cheon, KS. Park (Yangsan, Republic of Korea)

    Objective: We investigated the mutation spectrum of glucocerebrosidase (GBA) gene in Korean patients with Parkinson’s disease (GBA-PD). Background: Mutations in the GBA gene represent important…
  • 2023 International Congress

    Hand to mouth: differences between musicians’ hand and embouchure dystonia

    A. Lee, J. Doll-Lee, E. Altenmüller (Hannover, Germany)

    Objective: To assess differences in playing ability and outcome of patients with Musician’s Hand (FHD) and Embouchure Dystonia (ED). Background: Musician’s Dystonia (MD) is a…
  • 2023 International Congress

    Gut microbiota dysbiosis in Parkinson’s disease patients: a potential biomarker of disease severity and progression?

    R. Cerroni, M. Conti, M. Pierantozzi, V. D'Angelo, N. Mercuri, A. Teofani, D. Pietrucci, G. Chillemi, V. Unida, A. Stefani (Rome, Italy)

    Objective: To investigate gut microbiota alterations in Parkinson's disease (PD) along disease progression. Background: Gut microbiota dysbiosis is considered a hallmark in PD1. However, it is…
  • « Previous Page
  • 1
  • …
  • 158
  • 159
  • 160
  • 161
  • 162
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley